Accepted for Publication: July 27, 2022.
Published: September 13, 2022. doi:10.1001/jamanetworkopen.2022.31334
Open Access: This is an open access article distributed under the terms of the CC-BY License. © 2022 Smoot K et al. JAMA Network Open.
Corresponding Author: Sally Hodder, MD, Clinical & Translational Sciences Institute, West Virginia University School of Medicine, One Medical Center Drive, Morgantown, WV 26506 (firstname.lastname@example.org).
Author Contributions: Drs Perrotta and Hodder had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.
Concept and design: Tacker, Kimble, Wen, Marsh, Perrotta, Hodder.
Acquisition, analysis, or interpretation of data: Smoot, Yang, Tacker, Welch, Khodaverdi, Kimble, Wen, Amjad, Perrotta, Hodder.
Drafting of the manuscript: Smoot, Yang, Tacker, Khodaverdi, Kimble, Wen, Perrotta.
Critical revision of the manuscript for important intellectual content: Smoot, Yang, Tacker, Welch, Kimble, Wen, Amjad, Marsh, Perrotta, Hodder.
Statistical analysis: Yang, Khodaverdi, Wen.
Obtained funding: Marsh, Perrotta, Hodder.
Administrative, technical, or material support: Yang, Tacker, Welch, Kimble, Marsh, Perrotta, Hodder.
Supervision: Kimble, Perrotta, Hodder.
Conflict of Interest Disclosures: Dr Welch reported receiving grants from the State of West Virginia during the conduct of the study. Mr Kimble reported receiving grant funding from the state of West Virginia and the National Institutes of Health during the conduct of the study. Dr Marsh reported receiving grants from West Virginia University State funding during the conduct of the study and state and federal grants from West Virginia University outside the submitted work. Dr Hodder reported receiving grants from the National Institutes of Health and the West Virginia Department of Health and Human Services during the conduct of the study. No other disclosures were reported.
Funding/Support: This study was supported by grant BPH2200000001 from the West Virginia Department of Health and Human Services, Bureau of Public Health and partially supported by grants U54GM104942-05S2 and U54GM104942 from the National Institute of General Medical Sciences (Dr Hodder).
Role of the Funder/Sponsor: The funding sources had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and the decision to submit the manuscript for publication.
Additional Contributions: We gratefully acknowledge the staff, residents, and residents’ families of participating West Virginia nursing homes.
JT , Vandecasteele
S , De Roo
A , De Vriese
AS , Reynders
M . Humoral and cellular immunogenicity of the BNT162b2 messenger RNA coronavirus disease 2019 vaccine in nursing home residents. Clin Infect Dis
. 2021;73(11):2145-2147. doi:10.1093/cid/ciab300
DH , Oyebanji
OA , Keresztesy
et al. Significant reduction in vaccine-induced antibody levels and neutralization activity among healthcare workers and nursing home residents 6 months following coronavirus disease 2019 BNT162b2 mRNA vaccination. Clin Infect Dis
. Published online November 19, 2021. doi:10.1093/cid/ciab963
MW , Self
WH , Gaglani
et al; IVY Network. Effectiveness of mRNA vaccination in preventing COVID-19-associated invasive mechanical ventilation and death—United States, March 2021-January 2022. MMWR Morb Mortal Wkly Rep
. 2022;71(12):459-465. doi:10.15585/mmwr.mm7112e1